Published in Cancer Weekly, September 13th, 2011
"The Affibody molecules had affinities in the range of 0.12-3.8 nM. Cellular binding...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.